Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients

Lymph node positivity is a strong prognostic indicator in many cancers including gastric cancer. The extent of surgical resection directly influences the number of lymph nodes available for staging, with the lesser D1 resection that is standard practice in non-Asian countries typically providing fewer nodes for analysis. The widely used AJCC TNM staging system has been criticized for under-staging and stage migration where fewer than 15 nodes are resected, which is often the case in these populations. The ratio of positive to total nodes harvested – Lymph Node Ration (LNR) – has been proposed as an improved and more widely applicable prognostic indicator. The LNR is a reliable and accurate prognostic indicator of survival in a Western gastric cancer population. 9357 patients were acquired via a SEER case listing session with 2004–2011 gastric adenocarcinoma diagnoses. AJCC 7th edition nodal staging (N0: 0, N1:1–2, N2:3–6, N3:≥7 positive lymph nodes) and LNR positive nodal staging (PN0: 0%, PN1: 1–20%, PN2: 21–50%, PN3: 51–100% of examined nodes positive) were compared as respects seven year survivorship. Adjusted survival time ratios for AJCC nodal curves were less evenly distributed than were the percent positive nodal curves. Results of multiple regression reflected that survival time ratios of the percent positive nodal schema being more evenly spaced than those of the AJCC schema. Because BIC for AJCC, 41071.48, was larger than that for percent positive nodes, 41024.25, the LNR nodal system better explained survival than the AJCC nodal classification system. LNR produced reliable and internally consistent survival curves for this population. LNR is an effective tool to predict survival in a western gastric cancer patient population, where the majority of the patients have limited lymph node dissection. •Lymphnode Ratio (LNR) has been shown to augment staging in many cancers.•AJCC 7th Edition requires 15 lymph nodes for accurate staging.•SEER database was used to investigate LNR in western gastric cancer patients.•LNR produced reliable and even survival curves for gastric cancer population.•LNR may be used to augment staging in inadequate and limited nodal dissection

Prognostic Value of Metastatic Lymph Node Ratio in Pancreatic Cancer

WOS: 000461306700008PubMed ID: 30948872Lymph node involvement in pancreatic adenocancer is one of the strongest predictors of prognosis. However, the extent of lymph node dissection is still a matter of debate and number of dissected nodes varies widely among patients. In order to homogenize this diverse group of patients and more accurately predict their prognosis, we aimed to analyze the effect of metastatic lymph node ratio as an independent prognostic factor. We retrospectively analyzed medical recordings of 326 patients with pancreatic cancer who were treated in a tertiary medical oncology center over a 10-year period. Both in univariate and multivariate analyses, metastatic lymph node ratio proved to be a strong predictor of prognosis which was unaffected from heterogeneity of our patient population and can be used to facilitate predict prognosis of patients who underwent lymph node dissection to various extents and with future studies it can emerge as a successful tool for creating prognostic subgroups of the disease